We could not find any results for:
Make sure your spelling is correct or try broadening your search.
h5{margin-right:0cm;margin-left:0cm;font-size:10.0pt;font-family:"Times New Roman","serif";color:windowtext;border:none;font-weight:bold;}p{margin-top:5.0pt;margin-right:0cm;margin-bottom:5.0pt;margin...
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: ---------- STV Group PLC - Gla...
Update to Medium-Term Financial Guidance and 2023 Trading and Notice of Preliminary Results Three-year revenue CAGR increased to more than 35%, up from prior guidance of more than 30%Projected FY2024 ...
h5{margin-right:0cm;margin-left:0cm;font-size:10.0pt;font-family:"Times New Roman","serif";color:windowtext;border:none;font-weight:bold;}p{margin-top:5.0pt;margin-right:0cm;margin-bottom:5.0pt;margin...
p{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";}ol{margin-bottom:0cm;}ul{margin-bottom:0cm;}link{ color: blue }visited{ color: purple }.aw{size:595.0pt 842.0...
h5{margin-right:0cm;margin-left:0cm;font-size:10.0pt;font-family:"Times New Roman","serif";color:windowtext;border:none;font-weight:bold;}p{margin-top:5.0pt;margin-right:0cm;margin-bottom:5.0pt;margin...
p{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";}div.ax{size:595.3pt 841.9pt;margin:72.0pt 72.0pt 72.0pt 72.0pt;margin-left:22.5pt;margin-right:22.5pt}p.au{te...
p{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";}ol{margin-bottom:0cm;}ul{margin-bottom:0cm;}link{ color: blue }visited{ color: purple }.aw{size:595.0pt 842.0...
sup{font-size:80%}p{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";}ol{margin-bottom:0cm;}ul{margin-bottom:0cm;}link{ color: blue }visited{ color: purple }.ao{...
Oxford BioMedica PLC - Oxfordshire, England-based gene and cell therapy - Completes purchase of ABL Europe SAS from Institut Merieux SA, cementing the partnership between Oxford BioMedica and Institut...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -24 | -11.214953271 | 214 | 215 | 183.6 | 648242 | 191.41297127 | DE |
4 | 19 | 11.1111111111 | 171 | 220 | 167 | 483299 | 185.45129057 | DE |
12 | -6.2 | -3.16004077472 | 196.2 | 220 | 167 | 258956 | 186.00565077 | DE |
26 | -54 | -22.131147541 | 244 | 318.5 | 164.4 | 324712 | 204.92590876 | DE |
52 | -260 | -57.7777777778 | 450 | 473 | 164.4 | 222676 | 258.34536997 | DE |
156 | -830 | -81.3725490196 | 1020 | 1678 | 164.4 | 179975 | 604.83267989 | DE |
260 | -517.8 | -73.1562588302 | 707.8 | 1678 | 164.4 | 162120 | 661.4195726 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
ADVFN France ADVFN US ADVFN Korea |